| |
| |
|
| Insider
Information: |
Cavalier David |
| Relationship: |
Director |
| City: |
Research Triangle Pk |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,000 |
|
|
Indirect Shares
|
39,748,589 |
|
|
| Direct
Value |
$5,940 |
|
|
|
Indirect Value
|
$40 |
|
|
| Total
Shares |
39,750,589 |
|
|
| Total
Value |
$5,980 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeolus Pharmaceuticals Inc |
AOLS |
Director, 10% Owner |
|
0 |
2011-02-16 |
39,748,589 |
Premium* |
|
|
Anixa Biosciences Inc |
ANIX |
Director |
2019-04-29 |
2,000 |
2019-04-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIX |
Anixa Biosciences Inc |
Director |
– • – |
2019-04-29 |
4 |
B |
$4.21 |
$8,420 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-12 |
4 |
B |
$0.38 |
$9,600 |
I/I |
25,000 |
10,420 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-01-30 |
4 |
B |
$0.39 |
$778 |
I/I |
2,020 |
10,306,352 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-01-31 |
4 |
B |
$0.39 |
$39 |
I/I |
100 |
10,306,452 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-01 |
4 |
B |
$0.38 |
$3,800 |
I/I |
10,000 |
10,316,452 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-04 |
4 |
B |
$0.38 |
$2,698 |
I/I |
7,100 |
10,323,552 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-05 |
4 |
B |
$0.38 |
$11,521 |
I/I |
30,200 |
10,353,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-14 |
4 |
B |
$0.39 |
$3,900 |
I/I |
10,000 |
10,363,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-19 |
4 |
B |
$0.39 |
$2,379 |
I/I |
6,100 |
10,369,852 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-22 |
4 |
B |
$0.39 |
$390 |
I/I |
1,000 |
10,370,852 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-26 |
4 |
B |
$0.39 |
$2,735 |
I/I |
7,000 |
10,377,852 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-02-28 |
4 |
B |
$0.40 |
$435 |
I/I |
1,100 |
10,378,952 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-03 |
4 |
B |
$0.39 |
$1,950 |
I/I |
5,000 |
10,383,952 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-06 |
4 |
B |
$0.36 |
$3,875 |
I/I |
10,800 |
10,394,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-19 |
4 |
B |
$0.38 |
$3,800 |
I/I |
10,000 |
10,429,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-20 |
4 |
B |
$0.38 |
$7,600 |
I/I |
20,000 |
10,449,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-24 |
4 |
B |
$0.36 |
$3,600 |
I/I |
10,000 |
10,459,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-28 |
4 |
B |
$0.37 |
$3,700 |
I/I |
10,000 |
10,469,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-03-31 |
4 |
B |
$0.38 |
$1,900 |
I/I |
5,000 |
10,474,752 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-04-03 |
4 |
B |
$0.48 |
$7,248 |
I/I |
15,100 |
10,489,852 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-04-15 |
4 |
B |
$0.47 |
$23,300 |
I/I |
50,000 |
10,539,852 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-04-29 |
4 |
B |
$0.46 |
$9,200 |
I/I |
20,000 |
10,559,852 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-08-04 |
4 |
B |
$0.35 |
$7,135 |
I/I |
20,100 |
10,579,952 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-08-07 |
4 |
B |
$0.40 |
$80 |
I/I |
200 |
10,580,152 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-08-08 |
4 |
B |
$0.40 |
$2,420 |
I/I |
6,000 |
10,586,152 |
2.17 |
- |
|
81 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
